1. Home
  2. PRPH vs BREA Comparison

PRPH vs BREA Comparison

Compare PRPH & BREA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRPH
  • BREA
  • Stock Information
  • Founded
  • PRPH 1989
  • BREA 2022
  • Country
  • PRPH United States
  • BREA Ireland
  • Employees
  • PRPH N/A
  • BREA N/A
  • Industry
  • PRPH Biotechnology: Pharmaceutical Preparations
  • BREA Services-Misc. Amusement & Recreation
  • Sector
  • PRPH Health Care
  • BREA Consumer Discretionary
  • Exchange
  • PRPH Nasdaq
  • BREA Nasdaq
  • Market Cap
  • PRPH 14.5M
  • BREA 14.8M
  • IPO Year
  • PRPH 1997
  • BREA 2023
  • Fundamental
  • Price
  • PRPH $0.36
  • BREA $5.99
  • Analyst Decision
  • PRPH
  • BREA
  • Analyst Count
  • PRPH 0
  • BREA 0
  • Target Price
  • PRPH N/A
  • BREA N/A
  • AVG Volume (30 Days)
  • PRPH 15.3M
  • BREA 5.2K
  • Earning Date
  • PRPH 08-13-2025
  • BREA 01-01-0001
  • Dividend Yield
  • PRPH N/A
  • BREA N/A
  • EPS Growth
  • PRPH N/A
  • BREA N/A
  • EPS
  • PRPH N/A
  • BREA N/A
  • Revenue
  • PRPH $5,588,000.00
  • BREA $2,988,009.00
  • Revenue This Year
  • PRPH $221.82
  • BREA N/A
  • Revenue Next Year
  • PRPH N/A
  • BREA N/A
  • P/E Ratio
  • PRPH N/A
  • BREA N/A
  • Revenue Growth
  • PRPH N/A
  • BREA 151.51
  • 52 Week Low
  • PRPH $0.22
  • BREA $5.00
  • 52 Week High
  • PRPH $3.00
  • BREA $19.50
  • Technical
  • Relative Strength Index (RSI)
  • PRPH 53.22
  • BREA 42.43
  • Support Level
  • PRPH $0.28
  • BREA $5.71
  • Resistance Level
  • PRPH $0.35
  • BREA $6.56
  • Average True Range (ATR)
  • PRPH 0.02
  • BREA 0.25
  • MACD
  • PRPH 0.00
  • BREA -0.05
  • Stochastic Oscillator
  • PRPH 75.38
  • BREA 24.63

About PRPH ProPhase Labs Inc. (DE)

ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.

About BREA Brera Holdings PLC

Brera Holdings PLC focused on expanding social impact football by developing a international portfolio of emerging football clubs with increased opportunities to earn tournament prizes, gain sponsorships, and provide other professional football and related consulting services.

Share on Social Networks: